Limited coverage drugs – hydromorphone
Last updated on August 27, 2024
|
Generic Name / Strength / Form |
|
|---|---|
|
hydromorphone controlled release |
|
Criteria |
Approval period |
|---|---|
|
Pain management in a specified chronic pain (including cancer pain) diagnosis. PLUS For patients who are unable to tolerate or receive an adequate response to either the regular release dosage forms of hydromorphone alone OR the sustained release preparations of morphine. |
One Year |
Practitioner exemptions
Practitioners in the following specialty are not required to submit a Special Authority request for coverage:
- Oncologist (medical)
- Oncologist (radiation)
- Haematologist
Special notes
- Details regarding patient's condition and previous medication history are required.
- Renewal requests should provide an update on patient’s current dose and condition.
- Hydromorphone controlled-release is a regular benefit for patients registered with the BC Palliative Care Benefits Program.
Special Authority request form(s)
- Log in to eForms
- 5328 - General Special Authority request (PDF)